"10.1371_journal.pone.0076197","plos one","2013-09-24T00:00:00Z","Frédéric Raymond; Nancy Boucher; Robin Allary; Lynda Robitaille; Brigitte Lefebvre; Cécile Tremblay; Jacques Corbeil; Alain Gervaix","Centre de Recherche en Infectiologie and Département de Microbiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada; Laboratoire de Santé Publique du Québec, Institut National de Santé Publique, Ste-Anne-de-Bellevue, Québec, Canada; Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland","Conceived and designed the experiments: FR LR JC AG. Performed the experiments: FR NB RA. Analyzed the data: FR LR JC. Contributed reagents/materials/analysis tools: FR CT BL AG. Wrote the manuscript: FR NB RA LR BL CT JC AG.","Pfizer financed part of this study. Autogenomics inc. provided reagents necessary to conduct this study. Autogenomics inc. marketed the RVPPLUS assay though a licensing agreement of a patent by Drs. Raymond and Corbeil (Title : Multiplex Assay for Respiratory Viruses Patent application number: 20110046001). There is no discussion on marketing the serotyping assay described in the manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","09","Frédéric Raymond","FR",8,TRUE,4,3,3,8,TRUE,TRUE,FALSE,0,NA,FALSE
